Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-06 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |